Merck & Co., Inc. (ETR: 6MK)
Germany
· Delayed Price · Currency is EUR
94.80
-1.30 (-1.35%)
Jan 20, 2025, 5:35 PM CET
Merck & Co. Revenue
Merck & Co. had revenue of $16.66B USD in the quarter ending September 30, 2024, with 4.35% growth. This brings the company's revenue in the last twelve months to $63.17B, up 6.51% year-over-year. In the year 2023, Merck & Co. had annual revenue of $60.12B with 1.40% growth.
Revenue (ttm)
$63.17B
Revenue Growth
+6.51%
P/S Ratio
n/a
Revenue / Employee
$877.42K
Employees
72,000
Market Cap
240.69B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
Dec 31, 2019 | 39.12B | -3.17B | -7.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 20.96B |
Siemens Healthineers AG | 22.36B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.32B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.07B |
SCHOTT Pharma AG & Co. KGaA | 957.09M |
Merck & Co. News
- 1 day ago - High-Quality Dividend Growth Stocks Near 52-Week Lows: Merck Is Magnificent - Seeking Alpha
- 2 days ago - Exclusive: Kennedy played key role in vaccine case against Merck - Reuters
- 3 days ago - Organon: A Tricky 2025 Awaits, But I'm Happy With A >7% Dividend Yield - Seeking Alpha
- 3 days ago - What's In Store For Merck Stock In 2025? - Forbes
- 4 days ago - Merck & Co Inc (MRK) Announces Fourth-Quarter and Full-Year 2024 Earnings Call - GuruFocus
- 4 days ago - Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 - Wallstreet:Online
- 4 days ago - Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 - Business Wire
- 5 days ago - Price Over Earnings Overview: Merck & Co - Benzinga